Proliferative Glomerulonephritis with Monoclonal IgG Deposits Associated with Membrano-Proliferative Features: Case Report

Małgorzata Wągrowska-Danilewicz^1* and Marian Danilewicz²

¹Department of Nephropathology, Medical University of Łódź, Poland

²Department of Pathomorphology, Medical University of Łódź, Poland

*Corresponding Author:

Małgorzata Wągrowska-Danilewicz
Department of Nephropathology
Medical University of Łódź, Poland
Tel: +48 42 6757633
E-mail: [email protected]

Received Date: June 08, 2017; Accepted Date: August 22, 2017; Published Date: August 27, 2017

Citation: Wągrowska-Danilewicz M, Danilewicz M (2017) Proliferative Glomerulonephritis with Monoclonal IgG Deposits Associated with Membrano- Proliferative Features: Case Report. J Clin Case Rep 7:1003. doi: 10.4172/2165- 7920.10001003

Copyright: © 2017 Wągrowska-Danilewicz M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical Case Reports

Abstract

Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) is a recently described entity. It is featured by glomerular nonorganized monoclonal immunoglobulin G deposits. Monoclonal IgG deposits are associated with glomerular proliferative lesions, mimicking different types of immune-complex glomerulonephritis. We report two classic cases of PGNMID which fulfilled all criteria of this disease. We conclude that recognition of proliferative glomerulonephritis with monoclonal IgG deposits requires routine immunostaining for light chain and IgG isotype.

Keywords

Proliferative glomerulonephritis; Monoclonal IgG deposits; PGNMID

Introduction

Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) is a recently described entity [1,2]. The etiology of PGNMID is not fully understood. Patients with PGNMID present nephrotic-range proteinuria or nephrotic syndrome, hematuria and renal failure without clinical evidence of multiple myeloma or B-cell lymphoproliferative disorders [3,4]. Renal diseases caused by monoclonal IgG include light and heavy deposition disease, type 1 cryoglobulinemic disease, immunotactoid glomerulopathy, light and heavy amyloidosis, and fibrillary glomerulonephritis [5]. PGNMID is featured by glomerular nonorganized monoclonal immunoglobulin G deposits. Monoclonal IgG deposits are associated with glomerular proliferative lesions, mimicking different types of immune-complex glomerulonephritis [6- 15]. Diagnostic criteria of PGNMID include the presence of glomerular monoclonal IgG deposits restricted to a single IgG subclass and a single light-chain isotype, the presence of granular deposits by electron microscopy and the absence of clinical and laboratory evidence of cryoglobulin. The immune deposits in glomeruli are composed mostly of IgG3 kappa type. Human IgG is divided into four subclasses. Of the four subclasses, IgG3 has several properties that allow being “nephritogenic”. The prognosis of PGNMID is variable; about 22% patients progressed to end stage renal disease (ESRD). The disease can recur in the transplanted kidney [16,17]. Administration of immunosuppressive therapy including rituximab has been found to successfully ameliorate impaired renal function in patients with PGNMID [18].

Case Report

We report two cases of PGNMID with IgG3 monoclonal deposits in two females: 44-years-old (Case 1) and 61-years-old (Case 2). At presentation both patients had nephrotic syndrome. Renal failure was seen in an older woman.

Case 1

On admission to the Nephrology Department her blood pressure was 130/80 mmHg, her pulse rate was 74 beats per minute and her body temperature was 36.6°C. Physical examination showed edema of the lower limbs. Examination of the lungs, heart, abdomen, and central, and peripheral nervous systems showed no abnormalities. Complete blood counts revealed: white blood cells 4,400/mcL, red blood cells 3.8 million/ mcL, hemoglobin 11.5 g/dL. Serum biochemical analysis showed: total protein 4.5 g/dL, serum albumin 2.5 g/dL, serum creatine 0.79 mg/dL (eGFR 84.4 mL/min). Urinanalysis revealed proteinuria and hematuria. Urinary protein excretion was 4.7 g/24 h.

Case 2

On admission, the patient’s blood pressure was 130/80 mmHg. Her pulse rate was 76 beats per minute, and her body temperature was 36.3°C. Physical examination showed edema of the lower limbs. Examination of the lungs, heart, abdomen, central and peripheral nervous systems showed no abnormalities. Complete blood counts revealed: white blood cells 3,500/mcL, red blood cells 3.1 million/mcL, hemoglobin 8.5 g/dL. Serum biochemical analysis revealed: total protein 4.3 g/dL, serum albumin 2.3 g/dL, serum creatine 2,73 mg/dL (eGFR 19 mL/min). Urinanalysis revealed proteinuria. Urinary protein excretion was 6.7 g/24 h.

None of these patients had detectable levels of serum monoclonal IgG or overt multiple myeloma. None of them had paraproteinemia. Serum cryoglobulins titers and complement levels were normally in both patients. Antinuclear antibody, hepatitis B surface antigen, antihepatitis B virus antibody and rheumatoid factor were negative.

The renal biopsy was undergone in both patients. The samples of renal biopsy specimens were embedded in paraffin and sectioned at 2 μm, followed by H and E, Masson’s trichrome, periodic acid-Schiff, methenamine-silver, and Congo red staining. Congo red staining was completely negative in both cases. For immunofluorescence study (IF), the samples were sectioned in frozen conditions, followed by a direct staining for IgG, IgG1, IgG2, IgG3, IgG4, IgA, IgM, C3, C1q, kappa and lambda light chain. The electron microscopy (EM) examination was done with JEM 1011 electron microscopy after routine staining.

Renal tissue in Case 1 (a younger women) consisted of 21 glomeruli with 1 sclerosed, and renal tissue obtained from an older woman (case 2) consisted of 15 glomeruli with 2 sclerosed. The renal biopsy in both patients showed accentuated glomerular lobularity, mesangial hypercellularity and matrix expansion, segmental endocapillary proliferation, and glomerular basement membrane duplication (Figure 1). Interstitial fibrosis and tubular atrophy was seen in biopsy specimen in an older woman (Case 2).

Figure 1: Focal endocapillary proliferation, matrix expansion and thickening of the peripheral capillary walls. PAS stain, magn 200x.

By immunofluorescence, granular deposits were identified along capillary loop and focally in mesangium. IgG was the only immunoglobulin deposited. In a similar distribution to the IgG deposits, glomerular granular deposition of IgG3 (Figure 2), C3 and C1q was detected. Both cases showed light-chain isotype restriction: sole positivity for lambda (Case 1) (Figure 3) or kappa chain (Case 2). Immunostaining for IgG1, IgG2 and IgG4 was negative in both biopsy specimens.

Figure 2: Direct IF for IgG3. Gromerural positivity for IgG3 along the peripheral capillary walls and in mesangium, magn 200x.

Figure 3: Direct IF for λ light chain (case 1). Lambda light chains stain strongly positive along the peripheral capillary walls and mesangial areas, magn 200x.

Electron microscopy revealed nonorganized electron-dense subendothelial and mesangial deposits in both renal biopsy specimens (Figure 4).

Figure 4: Electron microscopy demonstrates dense deposits without any organized substructural features located within endothelial space and in the mesangial areas, magn 10000x.

Discussion

Proliferative glomerulonephritis with monoclonal IgG deposits, which was first described in 2004 by Nasr et al. [1], has been a recently reported renal disease accounting for 0.07% of the diagnoses by renal biopsy [6,19]. As was mentioned earlier, the diagnosis of PNGMID is based on several restricted criteria as renal biopsy findings of glomerulonephritis with glomerular immune deposits staining positive for heave chain IgG, negativity for IgA and IgM heavy chains and positive staining for a single IgG subclass (IgG1, IgG2, IgG3 or IgG4) [20]. Moreover, positive staining for a single light chain isotype indicating monoclonality should be noticed and predominantly granular dense deposits in mesangial, subendothelial or subepithelial location by electron microscopy. The cases with clinical or laboratory evidence of cryoglobulinemia should be excluded [2,3]. Only two of our 2153 immunofluorescence and electron-microscopy diagnoses of proliferative glomerulonephritides met all these very restricted criteria indicating that classic form of PGNMID is really very rare renal disease. This is noteworthy that not all reported up to now cases of proliferative glomerulonephritis with monoclonal IgG deposits fulfilled mentioned above criteria [3].

Conclusion

In summary, the presented cases demonstrate that recognition of PGNMID requires routine immunostaining for light chain and IgG isotype.

References

1. Nasr SH, Markowitz GN, Stokes MB, Seshan SV, Valderrama E, et al. (2004) Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 65: 85-96.
2. Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, et al. (2009) Proliferative glomerulonephritis with monoclonal IgG deposits. J Am SocNephrol 20: 2055-2064.
3. Fatima R, Iha R, Gowrishankar S Narayen G, Rao BS (2014) Proliferative glomerulonephritis associated with monoclonal immune deposits: A case report and review of literature. Indian J Nephrol 24: 376-379.
4. Gandhi K, Prasad D, Malhotra V, Beniwal P (2015) Glomerulonephritis with monoclonal IgG deposits. Indian J Nephrol 25: 187-188.
5. Sasaki H, Soma J (2015) Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: A poorly-understood disease spectrum. J NephrolTher S12:e001.
6. Komatsuda A, Nara M, Ohtani H, Nimura T, Sawada K, et al. (2012) Proliferative glomerulonephritis with monoclonal immunoglobulin light chain deposits: A rare entity mimicking immune-complex glomerulonephritis. Intern Med 51: 3273-3276.
7. Larsen CP, Ambruzs JM, Bonsib SM, Boils CL, Cossey LN, et al. (2014) Membranous-like glomeulopathy with masked IgG kappa deposits. Kidney Int 86: 154-161.
8. Oshio M,Fujii T, Kusaura T, Nagahama K (2013) Relapsing proliferative glomerulonephritis with monoclonal IgG deposits showing circumferential crescenitc glomerulonephritis. Clin Kidney J 6: 635-638.
9. Komatsuda A, Wakui H, Ohtani H, Nimura T, Sawada K (2010) Steroid-responsive nephrotic syndrome in a patient with proliferative glomerulonephritis with monoclonal IgG deposits with pure mesangial peoliferative features. NDT Plus 3: 357-359.
10. Yun S, Braunhut BL, Walker CN, Bhati W, Sussman AN, et al. (2014) Nephrotic syndrome secondary to proliferative glomerulonephritis with monoclonal immunoglobulin deposits of lambda light chain. Case Reports Nephrol 2014.
11. Ohashi R, Sakai Y, Otsuka T, Ohno D, Masuda Y, et al. (2013) Proliferative glomerulonephritis with monoclonal IgG2κ deposit successfully treated with steroids: A case report and review of the literature. CEN Case Rep 2: 197-203.
12. Fujita E, Shimizu A, Kaneko T, Masuda Y, Ishikara C, et al. (2012) Proliferative glomerulonephritis with monoclonal immunoglobulin G3 κ deposits in association with parvovirus B19 infection. Human Pathol 43: 2326-2333.
13. Ueki K, Matsukuma Y, Masutani K, Tsuchimoto A, Fujisaki K, et al. (2015) Membranoproliferative glomerulonephritis with predominant IgG2 and IgG3 deposition in a patient with IgG4-related disease. BMC Nephrology 16: 173.
14. Masai R, Wakui H, Komatsuda A, Togashi M, Maki N, et al. (2009) Characteristics of proliferative glomerulo-nephritis wit monoclonal IgG deposits associated with membranoproliferative features. ClinNephrol 72: 46-54.
15. Hara S, Tsukaguchi H, Oka T, Kusabe M, Masayuki M, et al. (2017) Monoclonal immunoglobulin-associated proliferative glomerulonephritis characterized by organized deposits of striated ultra-substructures: A case report. Ultrastructural Pathol 41: 301-307.
16. Al-Rabadi L, Francis JM, Henderson J, Ghai S (2015) Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts. Clin Kidney J 8:722-728.
17. Tsui T, Miura, M, Yanai M,Itami H, Ishii Y, et al. (2016)De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1κ subtype in a kidney allograft. Nephrology: 21 Suppl S1 44-47.
18. Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, et al. (2011) Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: Correlation with IgG subclass and response to ritiximab. Clin J Am SocNephrol 6: 1609-1616.
19. Wu D, Chen JS, Cheng DR, Chen H, Li X, et al. (2015) Recurrent proliferative glomerukonephritis with monoclonal IgG deposits after renal transplant which was insensitive to pulse therapy remitted by double filtration plasmapheresis. ExpClinTranplant13:467-470.
20. Hemminger J, Nadasdy G, Satoskar A, Brodsky SV, Nadasdy T (2016) IgG subclass in routine renal biopsy material. Am J SurgPathol 40: 617-626.